English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
European Commission
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Tabitha Fleming
| Jun 2, 2017
European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Robert Hadley
| Apr 5, 2017
European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Kyle Perrotti
| Mar 17, 2017
European Reference Networks help patients with complex diseases find diagnosis, treatment
Amanda Rupp
| Aug 9, 2016
Keytruda gains EC approval as advanced non-small cell lung cancer treatment
Amanda Rupp
| Jun 8, 2016
Positive CHMP opinion granted for Amgen relapsed multiple myeloma treatment
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Jun 2, 2016
Imbruvica gains approval for treating chronic lymphocytic leukemia
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
